home / stock / prtk / prtk quote
Last: | $2.23 |
---|---|
Change Percent: | 1.79% |
Open: | $2.19 |
Close: | $2.23 |
High: | $2.24 |
Low: | $2.19 |
Volume: | 4,764,401 |
Last Trade Date Time: | 09/20/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.23 | $2.19 | $2.23 | $2.24 | $2.19 | 4,764,401 | 09-20-2023 |
$2.19 | $2.19 | $2.19 | $2.2 | $2.18 | 5,142,882 | 09-19-2023 |
$2.19 | $2.19 | $2.19 | $2.2078 | $2.18 | 3,317,150 | 09-18-2023 |
$2.18 | $2.2 | $2.18 | $2.2 | $2.18 | 700,467 | 09-15-2023 |
$2.19 | $2.21 | $2.19 | $2.21 | $2.19 | 230,353 | 09-14-2023 |
$2.2 | $2.21 | $2.2 | $2.22 | $2.2 | 1,368,617 | 09-13-2023 |
$2.21 | $2.21 | $2.21 | $2.22 | $2.21 | 248,557 | 09-12-2023 |
$2.21 | $2.22 | $2.21 | $2.225 | $2.21 | 345,668 | 09-11-2023 |
$2.22 | $2.21 | $2.22 | $2.22 | $2.21 | 122,174 | 09-08-2023 |
$2.22 | $2.2 | $2.22 | $2.22 | $2.2 | 391,731 | 09-07-2023 |
$2.2 | $2.22 | $2.2 | $2.22 | $2.2 | 149,854 | 09-06-2023 |
$2.22 | $2.2 | $2.22 | $2.22 | $2.19 | 591,739 | 09-05-2023 |
$2.19 | $2.21 | $2.19 | $2.23 | $2.19 | 250,382 | 09-04-2023 |
$2.19 | $2.21 | $2.19 | $2.23 | $2.19 | 250,382 | 09-01-2023 |
$2.21 | $2.2 | $2.21 | $2.22 | $2.19 | 535,969 | 08-31-2023 |
$2.2 | $2.19 | $2.2 | $2.225 | $2.19 | 260,187 | 08-30-2023 |
$2.21 | $2.19 | $2.21 | $2.21 | $2.19 | 322,274 | 08-29-2023 |
$2.19 | $2.19 | $2.19 | $2.21 | $2.18 | 231,192 | 08-28-2023 |
$2.2 | $2.2 | $2.2 | $2.2125 | $2.19 | 232,385 | 08-25-2023 |
$2.2 | $2.19 | $2.2 | $2.21 | $2.18 | 452,820 | 08-24-2023 |
News, Short Squeeze, Breakout and More Instantly...
Paratek Pharmaceuticals Inc. Company Name:
PRTK Stock Symbol:
NASDAQ Market:
Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...
Paratek Pharmaceuticals Inc. (PRTK) is expected to report $-0.25 for Q3 2023
BOSTON, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military ...